nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—HCRT—narcolepsy	0.00623	0.00623	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00602	0.00602	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00589	0.00589	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00589	0.00589	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00588	0.00588	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00587	0.00587	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00587	0.00587	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00581	0.00581	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00581	0.00581	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00568	0.00568	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00567	0.00567	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00561	0.00561	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00559	0.00559	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00557	0.00557	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—HCRTR1—narcolepsy	0.00545	0.00545	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—HCRTR2—narcolepsy	0.00545	0.00545	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—P2RY11—narcolepsy	0.00527	0.00527	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00524	0.00524	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00504	0.00504	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00504	0.00504	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00503	0.00503	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00503	0.00503	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00498	0.00498	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00498	0.00498	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—NPS—narcolepsy	0.00489	0.00489	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—TAC1—narcolepsy	0.00489	0.00489	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00487	0.00487	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00485	0.00485	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00481	0.00481	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—TRH—narcolepsy	0.00474	0.00474	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—TRH—narcolepsy	0.00472	0.00472	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.00458	0.00458	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00456	0.00456	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—HCRT—narcolepsy	0.00448	0.00448	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00446	0.00446	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00437	0.00437	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00437	0.00437	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00424	0.00424	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00422	0.00422	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00414	0.00414	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00413	0.00413	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00409	0.00409	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—PENK—narcolepsy	0.00399	0.00399	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00393	0.00393	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00391	0.00391	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00384	0.00384	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00384	0.00384	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00383	0.00383	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00383	0.00383	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00379	0.00379	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00379	0.00379	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00371	0.00371	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.0037	0.0037	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00368	0.00368	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00367	0.00367	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00366	0.00366	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00364	0.00364	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00364	0.00364	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00344	0.00344	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00344	0.00344	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00342	0.00342	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00325	0.00325	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00321	0.00321	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0032	0.0032	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00315	0.00315	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00308	0.00308	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00308	0.00308	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00308	0.00308	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00308	0.00308	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00298	0.00298	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00298	0.00298	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.00294	0.00294	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.0028	0.0028	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.0028	0.0028	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.0028	0.0028	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00226	0.00226	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CHKB—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00153	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PENK—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CPT1B—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TRH—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000981	0.000981	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000981	0.000981	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000978	0.000978	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000978	0.000978	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000969	0.000969	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000969	0.000969	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000956	0.000956	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.000953	0.000953	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000944	0.000944	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.000902	0.000902	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000891	0.000891	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000891	0.000891	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000888	0.000888	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000888	0.000888	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.00088	0.00088	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.00088	0.00088	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000849	0.000849	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000841	0.000841	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.000838	0.000838	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.000761	0.000761	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.000748	0.000748	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NPS—narcolepsy	0.000748	0.000748	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000724	0.000724	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000722	0.000722	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000715	0.000715	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000635	0.000635	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000633	0.000633	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000627	0.000627	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.00059	0.00059	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000588	0.000588	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000583	0.000583	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000536	0.000536	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000534	0.000534	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000529	0.000529	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000526	0.000526	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000526	0.000526	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000525	0.000525	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000525	0.000525	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NPS—narcolepsy	0.00052	0.00052	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.00052	0.00052	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.00045	0.00045	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000317	0.000317	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000316	0.000316	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000313	0.000313	CbGpPWpGaD
